What's New

• 
  Mason Joe wrote a new blog entry:

  

  TELERADIOLOGY SERVICES – THE STEADILY GROWING VOLUME OF MEDICAL

  Teleradiology is a branch of telemedicine that uses telecommunication systems for the transmission of radiological images from one location to another. Additionally, it helps radiologists in interpreting various types of images, such as digitized X-rays, ...

  • December 17, 2021
• 
  Mason Joe wrote a new blog entry:

  

  TIL-BASED THERAPY MARKET - GAINING TRACTION IN THE PHARMACEUTIC

  Cancer is one of the leading causes of mortality, accounting for 0.6 million deaths in 2019, in the US alone. The International Agency for Research on Cancer (IARC) states that by 2040, the global burden of cancer is expected to grow to 27.5 million new c...

  • December 17, 2021
• 
  Mason Joe wrote a new blog entry:

  

  EFFECTIVE PROMOTIONAL STRATEGIES ADOPTED BY DEVELOPERS TO INCR

  Drug developers heavily rely on a number of broadcasting channels, which include direct-to-consumer (DTC) advertisements, product websites and conferences, to promote the use of their proprietary drugs. The importance of such promotions is evident from th...

  • December 17, 2021
• 
  Mason Joe wrote a new blog entry:

  

  Light Activated Therapies Market: Focus on Photodynamic Therapi

  To order this 140+ page report, which features 80+ figures and 120+ tables, please visit https://www.rootsanalysis.com/reports/light-activated-therapies-market.html
                 ...

  • December 10, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The progressive supranuclear palsy (PSP) therapies market, pred

  The exact cause of this rare disorder, which affects 5-17 in 100,000 people, is unknown; however, a complex interplay between different risk factors, including age, genetics and environment, is likely to contribute to the onset of this rare tauopathy
  &nb...

  • December 10, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The squamous non-small cell lung cancer market is projected to

  Over time, important advances in diagnosis and the development of versatile treatment options have translated into tangible improvements in the overall survival of lung cancer patients; several targeted therapies are being developed against squamous NSCLC...

  • December 10, 2021
• 
  Mason Joe wrote a new blog entry:

  

  Oligonucleotide Synthesis, Modification and Purification Servic

  To request for Customize Report – https://www.rootsanalysis.com/reports/304/request-sample.html
   
  Key Inclusions
  
  A detailed review of the current status of the market with respect to oligonucleotide manufacturers focused on research and di...

  • December 3, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The ophthalmic drugs contract manufacturing market – Roots Anal

  Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages
   
  Roots Analysis is pleased to ...

  • December 3, 2021
• 
  Mason Joe wrote a new blog entry:

  

  Patient Recruitment and Retention Services Market, 2019-2030 by

  A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, clos...

  • December 3, 2021
• 
  Mason Joe wrote a new blog entry:

  

  Human Factors Engineering and Usability Testing Services Market

  To order this detailed 200+ page report, please visit this - https://www.rootsanalysis.com/reports/human-factors-engineering-and-usability-testing-services.html
   
  Key Inclusions
  
  A detailed assessment of the current market landscape of companies ...

  • November 26, 2021
• 
  Mason Joe wrote a new blog entry:

  

  Continuous Manufacturing Market by Roots Analysis

  To order this 310+ page report, which features 110+ figures and 200+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/continuous-manufacturing/308.html
   
  Key Inclusions
  
  A detailed assessment of the overall landscap...

  • November 26, 2021
• 
  Mason Joe wrote a new blog entry:

  

  Elastomeric Closure Components Market by Roots Analysis

  To order this detailed 400+ page report, please visit this - https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html
   
  Key Inclusions
  
  A detailed assessment of the current ...

  • November 26, 2021
• 
  Mason Joe wrote a new blog entry:

  

  Cell and Gene Therapy Bioassay Service Market, 2021 – 2030

  To order this 305+ page report, which features 215+ figures and 250+ tables, please visit this link
   
  Key Inclusions
  
  A detailed assessment of the overall market landscape of the cell and gene therapy bioassay services market, providing informati...

  • November 19, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The pharmaceutical vials market is estimated to be worth USD 1

  Given the high demand for parenteral formulations and rising vaccination campaigns, there is an urgent need for safe and high-quality pharmaceutical vials for storing and distributing such formulations in large quantities
   
  Roots Analysis is please...

  • November 19, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The TIL-based therapies market is projected to be worth over US

  Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status
  &nb...

  • November 12, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The vascular disrupting agents market is projected to be worth

  Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indications
   
  London
   
  Roots Analysis has announced the addition of “Vascular Disrupting Agents...

  • November 12, 2021
• 
  Mason Joe wrote a new blog entry:

  

  Viral and non-viral vector manufacturing market

  The rapidly growing pipeline of genetically modified therapies reflects the surge in demand for high quality vectors, presenting lucrative opportunities for companies with the capabilities to manufacture viral and non-viral gene delivery solutions
   ...

  • November 12, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The synthetic lethality-based drugs and targets market is estim

  Advances in molecular screening technology have enabled the identification of novel synthetic lethal gene combinations, enabling the development of lead candidates that leverage the aforementioned phenomenon to offer therapeutic benefit.
   
  Roots An...

  • October 22, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The targeted protein degradation market is projected to grow at

   
  Roots Analysis has done a detailed study on Targeted Protein Degradation Market: Focus on Therapeutics and Technology Platforms (based on Degronimids, ENDTACs, Epichaperome Inhibitors, Hydrophobic Tags, IMiDs, LYTACs, Molecular Glues, PHOTACs, PRO...

  • October 22, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The novel vaccine delivery devices market is estimated to be wo

  Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient
   
  Roots Analysis is pleased...

  • October 8, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The peptides and macrocycle drug discovery services market is e

  Given the recent developments in healthcare, supporting safety and efficacy of peptide and affiliated macrocycle drugs, the industry is presently witnessing an increase in discovery and development initiatives related to such therapeutic modalities.
  &nbs...

  • October 8, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The ophthalmic drugs contract manufacturing market is estimated

  Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages
   
  Roots Analysis is pleased to ...

  • October 8, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The ophthalmic drugs contract manufacturing market is estimated

  Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages
   
  Roots Analysis is pleased to ...

  • September 24, 2021
• 
  Mason Joe wrote a new blog entry:

  

  Presently, close to 140 companies claim to be actively engaged

  A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, clos...

  • September 24, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The biopharmaceutical CROs market is projected to be worth USD

  Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status
  &nb...

  • September 17, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The TIL-based therapies market is projected to be worth over US

  Driven by the potential to confer sustained therapeutic effects and thereby, facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status
  &nb...

  • September 17, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The polycystic ovary syndrome market is growing at an annualize

  polycystic ovary syndrome affects 1 in 10 women of childbearing age. The exact cause of the condition is unknown; however, obesity, high levels of inflammation and insulin resistance are the common risk factors
   
  Roots Analysis is pleased to announ...

  • September 17, 2021
• 
  Mason Joe wrote a new blog entry:

  

  Patient Recruitment and Retention Services Marker

  A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers
   
  Roots Ana...

  • September 10, 2021
• 
  Mason Joe wrote a new blog entry:

  

  STING Pathway Targeting Therapeutics and Technologies, 2020-203

  STING, having generated significant interest within the medical research community, is currently considered one of the fastest growing areas of cancer immunotherapy and is being pursued by several large pharmaceutical companies
   
  Roots Analysis is ...

  • September 10, 2021
• 
  Mason Joe wrote a new blog entry:

  

  Large Volume Wearable Injectors Market by Roots Analysis

  Over the years, a rise in preference for self-administrable drugs / therapies has resulted in an increasing demand for user-friendly drug delivery solutions that are not only safe and efficient, but also promote therapy adherence
   
  London
   
  ...

  • September 10, 2021
• 
  Mason Joe wrote a new blog entry:

  

  Presently, close to 140 companies claim to be actively engaged

  A steadily increasing demand for study participants and the complexities associated with patient enrollment has imposed a significant burden on drug developer companies, prompting them to enlist the services of specialty service providers. Presently, clos...

  • September 3, 2021
• 
  Mason Joe wrote a new blog entry:

  

  Human Microbiome-based Products Market, growing at an annualize

  Over the years, extensive R&D efforts have enabled microbiome-based therapy / diagnostic developers to make significant strides, in terms of progressing proprietary product candidates into the clinic
   
  Roots Analysis has announced the addition of &...

  • September 3, 2021
• 
  Mason Joe Endocannabinoid
  System Targeted Therapeutics Market By Roots Analysis...  moreEndocannabinoid
  System Targeted Therapeutics Market By Roots Analysis
  
  
  
  
  So far, more
  than 100 different types of cannabinoids have been identified and there is a
  growing body of evidence supporting the benefits of this class of compounds in
  offering symptomatic relief for a wide variety of chronic health conditions
  
  
  
  
  
  
  
  London
  
  
  
  
  
  Roots Analysis has announced the
  addition of “Endocannabinoid System Targeted Therapeutics Market,
  2020-2030” report to its list of offerings.
  
  
  
  
  
  Over
  time, extensive R&D on the potential health benefits of cannabis, have
  enabled medical researchers to identify a number of pharmacologically active
  ingredients that offer clinical benefit, minus the addictive properties of the
  crude substance. Currently, several stakeholders in the pharmaceutical industry
  are actively engaged in the efforts to develop leads based on natural and
  synthetic derivatives of cannabinoids.
  
  
  
  
  
  To order this 250+ page report, which
  features 140+ figures and 170+ tables, please...    less

  

  • August 20, 2021
• 
  Mason Joe Global Preventive
  Vaccines Market by Roots...  moreGlobal Preventive
  Vaccines Market by Roots Analysis
  
  
  
  
  Although vaccines were solely responsible for the global
  eradication of smallpox (1980) and polio (2015), several vaccine-preventable
  diseases, such as measles and mumps, are still a threat; COVID-19 has been
  recently added to the list
  
  
  
  
  
  Roots Analysis is pleased to announce the publication of its recent
  study, titled, “Global Preventive
  Vaccines Market, 2020-2030”.
  
  
  
  
  
  The report features an extensive study of the current
  market landscape and future opportunities associated with the preventive
  vaccine domain. The study also features a detailed analysis of the key drivers
  and trends related to this evolving segment of the pharmaceutical industry.
  Amongst other elements, the report includes:
  
  
  §
  A detailed assessment of the current market landscape,
  featuring clinical-stage preventive vaccines.
  
  
  §
  A competitiveness analysis of preventive vaccine developers,
  featuring insightful pictorial summaries and representations.
  
  
  §...    less

  

  • August 20, 2021
• 
  Mason Joe The gene therapy
  market is projected to be worth USD 14.6 billion in 2030, claims Roots
  ...  moreThe gene therapy
  market is projected to be worth USD 14.6 billion in 2030, claims Roots
  Analysis
  
  
  
  
  Driven by the potential to treat the root cause of
  diseases, including rare clinical conditions and those that were previously
  deemed incurable, the gene therapies pipeline is growing, and the market
  anticipated to witness substantial growth, till 2030
  
  
  
  
  
  Roots Analysis has announced the addition of “Gene Therapy Market (4th Edition), 2020-2030” report to
  its list of offerings.
  
  
  
  
  
  Success
  of approved gene therapies has resulted in a surge in interest of biopharmaceutical
  developers in this rapidly evolving domain. Presently, the ability of gene
  therapies to treat diverse disease indications is considered among the most
  prominent drivers of this market. In addition, promising clinical results of
  pipeline candidates are anticipated to draw in more investments to support
  product development initiatives.
  
  
  
  
  
  To order this 720+
  page report, which features 220+ figures and 375+ tables, please...    less

  

  • August 13, 2021
• 
  Mason Joe Human
  Microbiome-based Products Market is growing at an annualized rate of over
  ...  moreHuman
  Microbiome-based Products Market is growing at an annualized rate of over
  40%.
  
  
  
  
  Over the years, extensive R&D efforts have
  established the basis for a wide range of microbiome-based therapeutic and
  diagnostic products, which may cause a paradigm shift in the way healthcare is
  delivered in the foreseen future
  
  
  
  
  
  
  
  Roots Analysis has announced the addition of “Human Microbiome Market, 2019-2030”
  report to its list of offerings.
  
  
  
  
  
  The concept of
  microbiome-based therapeutics has generated significant enthusiasm within the
  medical science community, defining a new frontier in the field of medicine.
  Despite having captured the interest of several venture capital firms and big
  pharma players, no microbiome-based therapeutic has been officially approved by
  an authorized medical product regulator. However, the current development
  pipeline of microbiome therapeutics has several promising candidates that are
  likely to result in commercial success stories soon.
  
  
  
  
  
  To order this...    less

  

  • August 13, 2021
• 
  Mason Joe The gene therapy
  market is estimated to be worth USD 11.6 billion in 2030, predicts Roots
  Analysis...  moreThe gene therapy
  market is estimated to be worth USD 11.6 billion in 2030, predicts Roots
  Analysis
  
  
  
  With multiple approved products,
  the field of gene therapies has gained substantial momentum over the last
  couple of decades; innovator companies are gradually progressing their
  proprietary therapy candidates with cautious optimism
  
  
  
  
  
  Roots Analysis is pleased to announce the publication of its recent study,
  titled, “Gene Therapy Market
  (3rd Edition), 2019-2030”.
  
  
  
  
  
  The report features an extensive study of the
  current market landscape of gene therapies,
  primarily focusing on gene augmentation-based therapies, oncolytic viral
  therapies and genome editing therapies. The study also features an elaborate
  discussion on the future potential of this evolving market. In addition to
  other elements, the study includes:
  
  
  § A
  detailed review of the overall landscape of gene therapies and genome editing
  therapies.
  
  
  § A
  discussion on the various types of viral and non-viral vectors.
  
  
  § ...    less

  • August 6, 2021
• 
  Mason Joe The medical device
  batteries market is projected to grow at an annualized rate of 12%, claims
  Roots...  moreThe medical device
  batteries market is projected to grow at an annualized rate of 12%, claims
  Roots Analysis
  
  
  
  
  An exponential
  increase in development efforts related to wearable medical devices and
  implants, has fueled a corresponding rise in demand for safe, compact,
  light-weight and high energy density batteries with longer life span
  
  
  
  
  
  Roots Analysis has announced the
  addition of “Medical
  Device Batteries: Focus on Implants and Wearable Medical Devices - Market
  Distribution by Battery Chemistry (Lithium, Zinc Air, Nickel and Others),
  Rechargeability (Rechargeable and Non-Rechargeable), Application (Hearing Aids,
  Patient Monitoring Devices, Drug Delivery Devices, Cardiovascular Medical
  Devices and Others) and Key Geographies (North America, Europe, Asia Pacific,
  Latin America, MENA and Rest of the World): Industry Trends and Global
  Forecasts, 2020-2030” report to its list of offerings.
  
  
  
  
  
  Battery-operated
  medical devices, such as cochlear implants, defibrillators, insulin pumps...    less

  

  • August 6, 2021
• 
  Mason Joe The market for
  single-use bioreactors is growing at an annualized rate of over 18%, claims
  Roots Analysis...  moreThe market for
  single-use bioreactors is growing at an annualized rate of over 18%, claims
  Roots Analysis
  
  
  Report Keywords- Single-Use
  Bioreactors, Bioreactor, Roots Analysis, Biotech, Analysis
  
  
  
  
  
  Single-use
  bioreactors are a revolutionary product of the process optimization efforts of
  drug manufacturers, offering a highly flexible approach to rapidly produce
  multiple drugs, while notably reducing downtime between batches and operational
  costs
  
  
  
  
  
  
  
  Roots Analysis has announced the addition of “Single-Use
  Bioreactors Market, 2021-2030” report to its list of offerings.
  
  
  
  
  
  Traditionally, stainless
  steel bioreactors were the preferred choice for production of biologics;
  however, over the past couple of decades, biopharmaceutical manufacturing has
  gradually witnessed a shift towards the use of single-use technologies. Apart
  from low contamination risk and better product yield, single-use bioreactors
  are easy-to-install and have a much smaller footprint, compared to the
  traditional...    less

  

  • July 30, 2021
• 
  Mason Joe Cloud-based
  solutions for drug discovery, development and manufacturing market is
  projected to grow at a CAGR of 15.4%, claims Roots...  moreCloud-based
  solutions for drug discovery, development and manufacturing market is
  projected to grow at a CAGR of 15.4%, claims Roots Analysis
  
  
  
  
  The growing complexities
  surrounding modern therapy development initiatives have caused biopharmaceutical
  companies to adopt available cloud-based solutions, to not only expedite
  associated timelines, but also cuts down overall cost
  
  
  
  
  
  
  
  Roots
  Analysis has announced the addition of “Cloud-based
  Solutions for Drug Discovery, Development and Manufacturing Market by Type of
  Cloud (Private, Public and Hybrid), Type of Service (Infrastructure as a
  Service (IaaS), Platform as a Service (PaaS) and Software as a Service (SaaS)),
  End-User (Biotech Vendors, Contract Research Organizations, Pharmaceutical
  Companies and Others), and Key Geographical Regions (North America, Europe,
  Asia, Middle East and North Africa, Latin America, and Rest of the World):
  Industry Trends and Global Forecasts, 2021-2030” report to its list of offerings.
  
  
  
  
  
  Modern...    less

  

  • July 23, 2021
• 
  Mason Joe Cancer biomarkers
  market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million
  in 2030, Roots...  moreCancer biomarkers
  market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million
  in 2030, Roots Analysis.
  
  
  
  
  Report Keywords – Cancer Biomarkers, Biomarkers Market, biomarkers, Roots
  Analysis
  
  
  
  
  
  Advances in
  biotechnology have enabled the identification of several novel biomarkers,
  which are presently being used for a variety of purposes, including diagnosis,
  drug development, clinical research and to facilitate therapy-related
  decisions.
  
  
  
  
  
  Roots
  Analysis is pleased to announce the
  publication of its recent study, titled, “Cancer Biomarkers Market:
  Focus on TMB, MSI / MMR and TILs Testing, 2019–2030.”
  
  
  
  
  
  The report features an extensive study of the current landscape and
  future outlook of the immuno-oncology biomarkers testing market (focusing
  particularly on TMB, MSI and TILs (CD3+, CD4+, CD8+, FOXP3+)). It provides an
  in-depth analysis, highlighting the capabilities of the various companies
  engaged in this domain. Amongst various elements, the report...    less

  • July 16, 2021
• 
  Mason Joe wrote a new blog entry:

  

  The antibody contract manufacturing market is projected to reac

  With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone
   
  Roots Analysis...

  • July 9, 2021
• 
  Mason Joe has just signed up. Say hello!

  • July 9, 2021